My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 284

    1.

    Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

    Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R.

    Diabetes. 2006 May;55(5):1484-90.PMID: 16644709 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data.

    Delzenne NM, Cani PD, Neyrinck AM.

    J Nutr. 2007 Nov;137(11 Suppl):2547S-2551S. Review.PMID: 17951500 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.

    Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM.

    J Endocrinol. 2005 Jun;185(3):457-65.PMID: 15930172 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice.

    Delmée E, Cani PD, Gual G, Knauf C, Burcelin R, Maton N, Delzenne NM.

    Life Sci. 2006 Aug 1;79(10):1007-13. Epub 2006 May 20.PMID: 16757002 [PubMed - indexed for MEDLINE]Related articles

    5.

    Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.

    Scrocchi LA, Hill ME, Saleh J, Perkins B, Drucker DJ.

    Diabetes. 2000 Sep;49(9):1552-60.PMID: 10969840 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.

    Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ.

    Diabetes. 1998 Apr;47(4):632-9.PMID: 9568697 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes.

    Claus TH, Pan CQ, Buxton JM, Yang L, Reynolds JC, Barucci N, Burns M, Ortiz AA, Roczniak S, Livingston JN, Clairmont KB, Whelan JP.

    J Endocrinol. 2007 Feb;192(2):371-80.PMID: 17283237 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

    Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Grémeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, Burcelin R.

    J Clin Invest. 2005 Dec;115(12):3554-63.PMID: 16322793 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.

    Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.

    J Biol Chem. 2003 Jan 3;278(1):471-8. Epub 2002 Oct 29.PMID: 12409292 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

    Cani PD, Neyrinck AM, Maton N, Delzenne NM.

    Obes Res. 2005 Jun;13(6):1000-7.PMID: 15976142 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.

    Liu X, Harada N, Yamane S, Kitajima L, Uchida S, Hamasaki A, Mukai E, Toyoda K, Yamada C, Yamada Y, Seino Y, Inagaki N.

    Life Sci. 2009 Jun 19;84(25-26):876-81. Epub 2009 Apr 7.PMID: 19358859 [PubMed - indexed for MEDLINE]Related articles

    12.

    Leptin sensitivity in nonobese glucagon-like peptide I receptor -/- mice.

    Scrocchi LA, Brown TJ, Drucker DJ.

    Diabetes. 1997 Dec;46(12):2029-34.PMID: 9392491 [PubMed - indexed for MEDLINE]Related articles

    13.

    beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.

    Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ.

    Diabetes. 2005 Feb;54(2):482-91.PMID: 15677506 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.

    Maida A, Lovshin JA, Baggio LL, Drucker DJ.

    Endocrinology. 2008 Nov;149(11):5670-8. Epub 2008 Jul 31.PMID: 18669601 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.

    Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB.

    Diabetes. 1998 Jul;47(7):1046-52.PMID: 9648827 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.

    Baggio LL, Kim JG, Drucker DJ.

    Diabetes. 2004 Dec;53 Suppl 3:S205-14.PMID: 15561912 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.

    Baggio LL, Huang Q, Cao X, Drucker DJ.

    Gastroenterology. 2008 Apr;134(4):1137-47. Epub 2008 Jan 11.PMID: 18313669 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.

    Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, Yoon JW, Jun HS.

    Diabetes. 2007 Jun;56(6):1671-9. Epub 2007 Mar 16.PMID: 17369525 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.

    Green BD, Irwin N, Gault VA, Bailey CJ, O'Harte FP, Flatt PR.

    J Endocrinol. 2005 May;185(2):307-17.PMID: 15845923 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy.

    De León DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA.

    Diabetes. 2003 Feb;52(2):365-71.PMID: 12540609 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity